Global Bio-Implants Market Research Report 2021

1 Bio-Implants Market Overview

• 1.1 Product Overview and Scope of Bio-Implants
• 1.2 Bio-Implants Segment by Type
  • 1.2.1 Global Bio-Implants Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Allograft
  • 1.2.3 Autograft
  • 1.2.4 Xenograft
• 1.3 Bio-Implants Segment by Application
  • 1.3.1 Bio-Implants Sales Comparison by Application: (2021-2027)
  • 1.3.2 Cardiovascular Implants
  • 1.3.3 Spinal Implants
  • 1.3.4 Orthopedics & Trauma
  • 1.3.5 Dental
  • 1.3.6 Others
• 1.4 Global Bio-Implants Market Size Estimates and Forecasts
  • 1.4.1 Global Bio-Implants Revenue 2016-2027
  • 1.4.2 Global Bio-Implants Sales 2016-2027
  • 1.4.3 Bio-Implants Market Size by Region: 2016 Versus 2021 Versus 2027

2 Bio-Implants Market Competition by Manufacturers

• 2.1 Global Bio-Implants Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Bio-Implants Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Bio-Implants Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Bio-Implants Manufacturing Sites, Area Served, Product Type
• 2.5 Bio-Implants Market Competitive Situation and Trends
  • 2.5.1 Bio-Implants Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Bio-Implants Players Market Share by Revenue
  • 2.5.3 Global Bio-Implants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Bio-Implants Retrospective Market Scenario by Region

• 3.1 Global Bio-Implants Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Bio-Implants Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Bio-Implants Market Facts & Figures by Country
  • 3.3.1 North America Bio-Implants Sales by Country
  • 3.3.2 North America Bio-Implants Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Bio-Implants Market Facts & Figures by Country
  • 3.4.1 Europe Bio-Implants Sales by Country
  • 3.4.2 Europe Bio-Implants Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Bio-Implants Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Bio-Implants Sales by Region
  • 3.5.2 Asia Pacific Bio-Implants Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Bio-Implants Market Facts & Figures by Country
  • 3.6.1 Latin America Bio-Implants Sales by Country
  • 3.6.2 Latin America Bio-Implants Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Bio-Implants Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Bio-Implants Sales by Country
  • 3.7.2 Middle East and Africa Bio-Implants Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Bio-Implants Historic Market Analysis by Type

• 4.1 Global Bio-Implants Sales Market Share by Type (2016-2021)
• 4.2 Global Bio-Implants Revenue Market Share by Type (2016-2021)
• 4.3 Global Bio-Implants Price by Type (2016-2021)

5 Global Bio-Implants Historic Market Analysis by Application

• 5.1 Global Bio-Implants Sales Market Share by Application (2016-2021)
• 5.2 Global Bio-Implants Revenue Market Share by Application (2016-2021)
• 5.3 Global Bio-Implants Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 AAP Implantate
  • 6.1.1 AAP Implantate Corporation Information
  • 6.1.2 AAP Implantate Description and Business Overview
  • 6.1.3 AAP Implantate Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 AAP Implantate Product Portfolio
  • 6.1.5 AAP Implantate Recent Developments/Updates
• 6.2 Abbott Laboratories
  • 6.2.1 Abbott Laboratories Corporation Information
  • 6.2.2 Abbott Laboratories Description and Business Overview
  • 6.2.3 Abbott Laboratories Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Abbott Laboratories Product Portfolio
  • 6.2.5 Abbott Laboratories Recent Developments/Updates
• 6.3 Bausch And Lomb Incorporated
  • 6.3.1 Bausch And Lomb Incorporated Corporation Information
  • 6.3.2 Bausch And Lomb Incorporated Description and Business Overview
  • 6.3.3 Bausch And Lomb Incorporated Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Bausch And Lomb Incorporated Product Portfolio
  • 6.3.5 Bausch And Lomb Incorporated Recent Developments/Updates
• 6.4 Biomet
  • 6.4.1 Biomet Corporation Information
  • 6.4.2 Biomet Description and Business Overview
  • 6.4.3 Biomet Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Biomet Product Portfolio
  • 6.4.5 Biomet Recent Developments/Updates
• 6.5 Biotronik Se & Co.Kg
  • 6.5.1 Biotronik Se & Co.Kg Corporation Information
  • 6.5.2 Biotronik Se & Co.Kg Description and Business Overview
  • 6.5.3 Biotronik Se & Co.Kg Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Biotronik Se & Co.Kg Product Portfolio
  • 6.5.5 Biotronik Se & Co.Kg Recent Developments/Updates
• 6.6 Boston Scientific Corporation
  • 6.6.1 Boston Scientific Corporation Corporation Information
  • 6.6.2 Boston Scientific Corporation Description and Business Overview
  • 6.6.3 Boston Scientific Corporation Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Boston Scientific Corporation Product Portfolio
  • 6.6.5 Boston Scientific Corporation Recent Developments/Updates
• 6.7 Cook Group
  • 6.6.1 Cook Group Corporation Information
  • 6.6.2 Cook Group Description and Business Overview
  • 6.6.3 Cook Group Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Cook Group Product Portfolio
  • 6.7.5 Cook Group Recent Developments/Updates
• 6.8 C.R. Bard
  • 6.8.1 C.R. Bard Corporation Information
  • 6.8.2 C.R. Bard Description and Business Overview
  • 6.8.3 C.R. Bard Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 C.R. Bard Product Portfolio
  • 6.8.5 C.R. Bard Recent Developments/Updates
• 6.9 Edwards Lifesciences Corporation
  • 6.9.1 Edwards Lifesciences Corporation Corporation Information
  • 6.9.2 Edwards Lifesciences Corporation Description and Business Overview
  • 6.9.3 Edwards Lifesciences Corporation Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Edwards Lifesciences Corporation Product Portfolio
  • 6.9.5 Edwards Lifesciences Corporation Recent Developments/Updates
• 6.10 Endo Health Solutions
  • 6.10.1 Endo Health Solutions Corporation Information
  • 6.10.2 Endo Health Solutions Description and Business Overview
  • 6.10.3 Endo Health Solutions Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Endo Health Solutions Product Portfolio
  • 6.10.5 Endo Health Solutions Recent Developments/Updates
• 6.11 Johnson & Johnson
  • 6.11.1 Johnson & Johnson Corporation Information
  • 6.11.2 Johnson & Johnson Bio-Implants Description and Business Overview
  • 6.11.3 Johnson & Johnson Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Johnson & Johnson Product Portfolio
  • 6.11.5 Johnson & Johnson Recent Developments/Updates
• 6.12 Integra Lifesciences Holdings Corporation
  • 6.12.1 Integra Lifesciences Holdings Corporation Corporation Information
  • 6.12.2 Integra Lifesciences Holdings Corporation Bio-Implants Description and Business Overview
  • 6.12.3 Integra Lifesciences Holdings Corporation Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Integra Lifesciences Holdings Corporation Product Portfolio
  • 6.12.5 Integra Lifesciences Holdings Corporation Recent Developments/Updates
• 6.13 Integrated Orbital Implants
  • 6.13.1 Integrated Orbital Implants Corporation Information
  • 6.13.2 Integrated Orbital Implants Bio-Implants Description and Business Overview
  • 6.13.3 Integrated Orbital Implants Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Integrated Orbital Implants Product Portfolio
  • 6.13.5 Integrated Orbital Implants Recent Developments/Updates
• 6.14 Lifenet Health
  • 6.14.1 Lifenet Health Corporation Information
  • 6.14.2 Lifenet Health Bio-Implants Description and Business Overview
  • 6.14.3 Lifenet Health Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Lifenet Health Product Portfolio
  • 6.14.5 Lifenet Health Recent Developments/Updates
• 6.15 Medtro
  • 6.15.1 Medtro Corporation Information
  • 6.15.2 Medtro Bio-Implants Description and Business Overview
  • 6.15.3 Medtro Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Medtro Product Portfolio
  • 6.15.5 Medtro Recent Developments/Updates
• 6.16 Mimedx Group
  • 6.16.1 Mimedx Group Corporation Information
  • 6.16.2 Mimedx Group Bio-Implants Description and Business Overview
  • 6.16.3 Mimedx Group Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Mimedx Group Product Portfolio
  • 6.16.5 Mimedx Group Recent Developments/Updates
• 6.17 Orthofix International
  • 6.17.1 Orthofix International Corporation Information
  • 6.17.2 Orthofix International Bio-Implants Description and Business Overview
  • 6.17.3 Orthofix International Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Orthofix International Product Portfolio
  • 6.17.5 Orthofix International Recent Developments/Updates
• 6.18 Smith & Nephew
  • 6.18.1 Smith & Nephew Corporation Information
  • 6.18.2 Smith & Nephew Bio-Implants Description and Business Overview
  • 6.18.3 Smith & Nephew Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 Smith & Nephew Product Portfolio
  • 6.18.5 Smith & Nephew Recent Developments/Updates
• 6.19 Sorin
  • 6.19.1 Sorin Corporation Information
  • 6.19.2 Sorin Bio-Implants Description and Business Overview
  • 6.19.3 Sorin Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.19.4 Sorin Product Portfolio
  • 6.19.5 Sorin Recent Developments/Updates
• 6.20 Abbott
  • 6.20.1 Abbott Corporation Information
  • 6.20.2 Abbott Bio-Implants Description and Business Overview
  • 6.20.3 Abbott Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.20.4 Abbott Product Portfolio
  • 6.20.5 Abbott Recent Developments/Updates

7 Bio-Implants Manufacturing Cost Analysis

• 7.1 Bio-Implants Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Bio-Implants
• 7.4 Bio-Implants Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Bio-Implants Distributors List
• 8.3 Bio-Implants Customers

9 Bio-Implants Market Dynamics

• 9.1 Bio-Implants Industry Trends
• 9.2 Bio-Implants Growth Drivers
• 9.3 Bio-Implants Market Challenges
• 9.4 Bio-Implants Market Restraints

10 Global Market Forecast

• 10.1 Bio-Implants Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Bio-Implants by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Bio-Implants by Type (2022-2027)
• 10.2 Bio-Implants Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Bio-Implants by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Bio-Implants by Application (2022-2027)
• 10.3 Bio-Implants Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Bio-Implants by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Bio-Implants by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List